• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. AZUR CX DETACHABLE; DEVICE VASCULAR FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. AZUR CX DETACHABLE; DEVICE VASCULAR FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number 45-750617
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/15/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device was stated to be available for return to the manufacturer for analysis, but it has not yet been returned.The alleged product issue could not be confirmed.If the device is received at a later date, an investigation will be performed and a supplemental mdr will be submitted.A search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.
 
Event or Problem Description
It was reported that the embolization coil implant detached unexpectedly.It was reported that there was no patient injury.There was a cancellation in the case.
 
Event or Problem Description
As reported: embolization coil implant detached unexpectedly.There was no patient injury.There was no cancellation of the case reported.
 
Additional Manufacturer Narrative
The investigation found the implant coil stretched and broken at the proximal section, which is consistent with the alleged product issue.The pusher and the portion of the implant proximal to the break site were not returned for evaluation.The physical evaluation of the device could not identify the conditions or circumstances that led to the stretched and broken implant, but the damage is consistent with the device experiencing forces exceeding the implant's yield and tensile strength.Correction: the age of the patient is not 12 months.It is not known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AZUR CX DETACHABLE
Common Device Name
DEVICE VASCULAR FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise
aliso viejo, CA 92656
7142478000
MDR Report Key22866002
Report Number2032493-2025-90425
Device Sequence Number13096016
Product Code KRD
UDI-Device Identifier00812636021041
UDI-Public00812636021041
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K151358
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Pharmacist
Type of Report Initial,Followup
Report Date (Section B) 09/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number45-750617
Device Catalogue Number45-750617
Device Lot Number0000470628
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/31/2025
Supplement Date Received by Manufacturer09/08/2025
Initial Report FDA Received Date08/21/2025
Supplement Report FDA Received Date09/11/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/29/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age12 MO
Patient SexUnknown
-
-